Owens & Minor (OMI) Q1 Earnings Top Estimates

Company Performance - Owens & Minor reported quarterly earnings of $0.23 per share, exceeding the Zacks Consensus Estimate of $0.20 per share, and up from $0.19 per share a year ago, representing a 15% earnings surprise [1] - The company posted revenues of $2.63 billion for the quarter ended March 2025, slightly missing the Zacks Consensus Estimate by 1.43%, but up from $2.61 billion year-over-year [2] - Over the last four quarters, Owens & Minor has surpassed consensus EPS estimates four times and topped consensus revenue estimates three times [2] Stock Outlook - The stock has underperformed, losing about 40.6% since the beginning of the year, compared to the S&P 500's decline of 4.3% [3] - The current consensus EPS estimate for the coming quarter is $0.32 on revenues of $2.72 billion, and for the current fiscal year, it is $1.64 on revenues of $11.18 billion [7] - The estimate revisions trend for Owens & Minor is mixed, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] Industry Context - The Medical - Products industry, to which Owens & Minor belongs, is currently in the bottom 32% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Owens & Minor's stock performance [5]